![](/img/cover-not-exists.png)
The combination of camrelizumab and apatinib obtained ongoing partial remission for a patient with osimertinib-resistant non-small cell lung cancer: case report
Cong, Xiufeng, Chen, Jun, Zheng, WeiVolume:
9
Journal:
Annals of Palliative Medicine
DOI:
10.21037/apm-19-462
Date:
October, 2020
File:
PDF, 1.15 MB
2020